Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration
- 12 July 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Safety
- Vol. 4 (4) , 779-794
- https://doi.org/10.1517/14740338.4.4.779
Abstract
This systematic review discusses the proposed uses, dosing parameters, adverse effects, toxicology, interactions and mechanism of action of kava. The widespread concern regarding the potential hepatotoxicity of kava is discussed. A recommendation is made to consolidate and analyse available reports and to continue postmarket surveillance in an international repository to prevent duplicates and promote collection of thorough details at the time of each report so that any association with kava is clearly defined.Keywords
This publication has 77 references indexed in Scilit:
- Kava treatment in patients with anxietyPhytotherapy Research, 2004
- Hepatic injury due to traditional aqueous extracts of kava root in New CaledoniaEuropean Journal of Gastroenterology & Hepatology, 2003
- Kava–Kava administration reduces anxiety in perimenopausal womenMaturitas, 2003
- Safety concerns about kava not unique.The Lancet, 2002
- Second thoughts about kavaThe American Journal of Medicine, 2002
- Safety concerns about kavaThe Lancet, 2002
- Hepatitis aguda ictérica secundaria a kavaGastroenterología y Hepatología, 2002
- Kava HepatotoxicityAnnals of Internal Medicine, 2001
- Drug points: Hepatitis associated with Kava, a herbal remedy for anxietyBMJ, 2001
- Kava: an overviewJournal of Ethnopharmacology, 1992